Trials of semaglutide in patients with Alzheimer’s and CagriSema in obese patients diabetes could give investors reason to be optimistic, Intron Health’s analysts said

European markets were trading higher on Tuesday, in a shortened trading session for Christmas Eve. The pan-European Stoxx 600 was up by around 0.3% during morning deals, with all sectors in positive territory.

Shares in Ozempic maker Novo Nordisk tumbled after an experimental anti-obesity shot fell short of expectations. The shares fell more than 20% in Copenhagen, closing at their lowes

New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way investors view emerging candidates.

European markets are set to open higher on Tuesday, in a shortened trading session for Christmas Eve. London's FTSE 100 is slated to gain 56 points to open at 8,140, according to data from IG, while France's CAC 40 index is expected to start the session 46 points higher at 7,

London (UKX) +0.33% will close early for Christmas. Germany (DAX:IND) closed for Chritsmas France (CAC:IND) +0.38% set to close early. Prime Minister François Bayrou pledged to cut the country's budget deficit to near 5%.